Shah Gaurav

CIK 1725922
Transactions on file
13
Open-market buys
1
Win rate (buys)
0%
1 scored
Avg % since filing (buys)
-53.0%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-08-212026-08-18RCKT
ROCKET PHARMACEUTICALS, INC.
CEO
Sale2,293$7.8K-29.3%open →
2026-08-172026-08-13RCKT
ROCKET PHARMACEUTICALS, INC.
CEO
Sale2,837$9.6K-29.3%open →
2026-05-262026-05-21RCKT
ROCKET PHARMACEUTICALS, INC.
CEO
Sale55,684$171.8K-22.6%open →
2026-05-262026-05-21RCKT
ROCKET PHARMACEUTICALS, INC.
CEO
Exer.76,490$129.3K+41.3%open →
2026-05-212026-05-19RCKT
ROCKET PHARMACEUTICALS, INC.
CEO
Sale2,409$7.3K-20.7%open →
2026-05-142026-05-13RCKT
ROCKET PHARMACEUTICALS, INC.
CEO
Sale2,728$9.8K-33.7%open →
2025-02-132025-02-11RCKT
ROCKET PHARMACEUTICALS, INC.
OfficerDirector
CEO
Grant81,655$0.00—open →
2025-02-252025-02-21RCKT
ROCKET PHARMACEUTICALS, INC.
OfficerDirector
CEO
Sale16,303$172.5K-77.4%open →
2025-04-142025-04-10RCKT
ROCKET PHARMACEUTICALS, INC.
OfficerDirector
CEO
Buy20,000$101.6K-53.0%open →
2025-05-202025-05-16RCKT
ROCKET PHARMACEUTICALS, INC.
OfficerDirector
CEO
Sale3,621$23.6K-63.4%open →
2025-05-222025-05-20RCKT
ROCKET PHARMACEUTICALS, INC.
OfficerDirector
CEO
Sale2,253$14.5K-62.9%open →
2025-11-202025-11-18RCKT
ROCKET PHARMACEUTICALS, INC.
CEO
Sale6,276$18.7K-19.9%open →
2025-08-202025-08-18RCKT
ROCKET PHARMACEUTICALS, INC.
OfficerDirector
CEO
Tax2,234$6.8K-21.6%open →